<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">akusherstvo</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics, Gynecology and Reproduction</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство, Гинекология и Репродукция</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7347</issn><issn pub-type="epub">2500-3194</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2313-7347.2017.11.1.074-080</article-id><article-id custom-type="elpub" pub-id-type="custom">akusherstvo-397</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW ARTICLE</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЙ ОБЗОР</subject></subj-group></article-categories><title-group><article-title>BREAST CANCER AND PREGNANCY</article-title><trans-title-group xml:lang="ru"><trans-title>РАК МОЛОЧНОЙ ЖЕЛЕЗЫ И БЕРЕМЕННОСТЬ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дадак</surname><given-names>К.</given-names></name><name name-style="western" xml:lang="en"><surname>Dadak</surname><given-names>Ch.</given-names></name></name-alternatives><bio xml:lang="ru"><p>профессор Университетской клиники акушерства и гинекологии Вены. Руководитель международного центра последипломного образования по проблемам женского здоровья. Тел.: +43140400/29100; факс: +431404002775</p></bio><bio xml:lang="en"><p>MD, Professor, University Clinic of obstetrics and gynecology, Center for teaching International postgraduate training in women's health. Address: AKH, Wдhringer Gьrtel 18-20/8C 1090 Vienna, Austria. Tel.: +43140400/29100; fax: +4314040027750</p></bio><email xlink:type="simple">christian.dadak@meduniwien.ac.at</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макацария</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Makatsariya</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., член-корреспондент РАН, профессор, заведующий кафедрой акушерства и гинекологии медико-профилактического факультета Первого МГМУ им. И.М. Сеченова. Адрес: ул. Трубецкая, 8, стр. 2, Москва, Россия,  119048. Тел.: +7(495)7885840</p></bio><bio xml:lang="en"><p>MD, corresponding member of the Russian Academy of Sciences, Professor, Head of the Department of Obstetrics and Gynecology, Faculty of Medical and Preventive, I.M. Sechenov First Moscow State Medical University. Address: ul. Trubetskaya, 8, str. 2, Moskva, Russia, 119048. Tel.: +7(495)7885840</p></bio><email xlink:type="simple">gemostasis@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Университетская клиника акушерства и гинекологии</institution><country>Австрия</country></aff><aff xml:lang="en"><institution>Medical University of Vienna</institution><country>Austria</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>17</day><month>06</month><year>2017</year></pub-date><volume>11</volume><issue>1</issue><fpage>74</fpage><lpage>80</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Dadak C., Makatsariya A.D., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Дадак К., Макацария А.Д.</copyright-holder><copyright-holder xml:lang="en">Dadak C., Makatsariya A.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.gynecology.su/jour/article/view/397">https://www.gynecology.su/jour/article/view/397</self-uri><abstract><p>25 evidenced based clinical practice guidelines for fertility preservation in cancer patients exist. Breast Cancer in Pregnancy is a rare problem but the incidence is growing, because pregnancy will be delayed in elder age groups. Diagnosis of Breast Cancer is often delayed. If there is a mass, you have to do at first an ultrasound and than mammography if it is necessary. A tumor should be biopsied. Each kind of surgery is possible. Sentinel lymphnode dissection is controversial discussed. It is because of the blue dye, because this substance is not allowed during pregnancy. Technetium is allowed, but will be not accepted by the mother, because of fear of radiance. Radiation and hormonal treatment should be postponed after pregnancy. Chemotherapy can be done after 16 week of gestation. Delivery should not be in the first 3 weeks after chemotherapy, because the nadir of white blood cells should not be at the time of delivery to avoid infection. The fetal outcome is quite normal except weight, because of preterm delivery and growth retardation. Termination of pregnancy will not optimize the cancer prognosis. Pregnancy after breast cancer treatment is possible, perhaps with better prognosis, but that can be due to the healthy mother effect. Because the most recurrence are in the first two years, women should wait 2 years and cryopreservation of ovarian tissue, eggs or embryos before chemotherapy should be done.</p></abstract><trans-abstract xml:lang="ru"><p>На сегодня имеются 25 подтвержденных клинической практикой рекомендаций по сохранению фертильности у больных раком. Рак молочной железы при беременности встречается нечасто, но с недавнего времени количество случаев возрастает, поскольку беременность все чаще наблюдается и в старших возрастных группах. Во многих случаях диагноз рака молочной железы запаздывает. Если пальпируется масса в молочной железе, женщина должна сначала сделать УЗИ и уже затем – маммографию, если это необходимо. При подозрении на опухоль – биопсия обязательна. Хирургические способы лечения весьма разнообразны. Возможность иссечения сторожевых лимфатических узлов неопределенна, поскольку используемый при этом синий краситель противопоказан беременным. Технеций разрешен к применению, однако будущие мамы не готовы пользоваться этим радиоактивным изотопом. Радиационное и гормональное лечение следует отложить до окончания беременности. Химиотерапию можно проводить после 16 недель гестации. Сроки лечения следует рассчитать так, чтобы роды не случились в течение первые 3 недели после химиотерапии. Причина в том, что вызванная химиотерапией лейкопения не должна совпадать со сроком родов, во избежание инфекций. Разрешение от беременности проходит нормально; вес новорожденного обычно снижен из-за преждевременных родов и задержки роста плода. Досрочное прекращение беременности не приводит к улучшению прогноза рака. Беременность после лечения рака молочной железы возможна, причем с лучшим исходом, но это может быть проявлением «эффекта здоровой матери». Поскольку большинство рецидивов рака приходится на первые два года после лечения, женщинам не рекомендуется беременеть в течение этих двух лет. До начала химиотерапии рекомендуется провести криоконсервацию ткани яичников, яйцеклеток или эмбрионов.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Рак молочной железы</kwd><kwd>беременность</kwd><kwd>опухоль</kwd><kwd>химиотерапия</kwd><kwd>криоконсервация.</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Breast Cancer</kwd><kwd>pregnancy</kwd><kwd>tumor</kwd><kwd>chemotherapy</kwd><kwd>cryopreservation.</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ventura S.J. First birth to older mother 1970-86. Am J Public Health. 1989; 79 (12): 1675-1677.</mixed-citation><mixed-citation xml:lang="en">Ventura S.J. First birth to older mother 1970-86. Am J Public Health. 1989; 79 (12): 1675-1677.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Woo J.C., Yu T., Huvud T.C. Breast Cancer in Pregnancy: a literature review. Breast J. 2016; 22 (6): 657-661. Arch surg. 2003; 138-91.</mixed-citation><mixed-citation xml:lang="en">Woo J.C., Yu T., Huvud T.C. Breast Cancer in Pregnancy: a literature review. Breast J. 2016; 22 (6): 657-661. Arch surg. 2003; 138-91.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Loibl S., Minkwitz G., Groyn K. et al. Breast Carcinoma during pregnancy. Cancer. 2006; 106 (2): 237-246.</mixed-citation><mixed-citation xml:lang="en">Loibl S., Minkwitz G., Groyn K. et al. Breast Carcinoma during pregnancy. Cancer. 2006; 106 (2): 237-246.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Nettleton J., Long J., Kuban D. et al. Breast Cancer during pregnancy: quantifying the risk of treatment delay. Obstet Gynecol. 1996; 87: 414.5.</mixed-citation><mixed-citation xml:lang="en">Nettleton J., Long J., Kuban D. et al. Breast Cancer during pregnancy: quantifying the risk of treatment delay. Obstet Gynecol. 1996; 87: 414.5.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Navrozoglou I., Vrekoussis T., Kontostolis E. et al. Breast cancer during pregnancy : a mini- review. Eur J Surg Oncol. 2008; 34: 837-43.</mixed-citation><mixed-citation xml:lang="en">Navrozoglou I., Vrekoussis T., Kontostolis E. et al. Breast cancer during pregnancy : a mini- review. Eur J Surg Oncol. 2008; 34: 837-43.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ishida T., Yokoe T., Kasumi F. et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res. 1992; 83: 1143-49.</mixed-citation><mixed-citation xml:lang="en">Ishida T., Yokoe T., Kasumi F. et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res. 1992; 83: 1143-49.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Goldsmith H.S. Milk-rejection sign of breast cancer. Am J Surg. 1974; 27: 280.</mixed-citation><mixed-citation xml:lang="en">Goldsmith H.S. Milk-rejection sign of breast cancer. Am J Surg. 1974; 27: 280.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Middleton L.P., Anim M., Gwyn K., Theriaulr R., Satim A. Breast Carcinoma in pregnant women. Cancer. 2003; 98 (859) 1055-1060.</mixed-citation><mixed-citation xml:lang="en">Middleton L.P., Anim M., Gwyn K., Theriaulr R., Satim A. Breast Carcinoma in pregnant women. Cancer. 2003; 98 (859) 1055-1060.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Amant F., Deckers S., Van Calsteren K. et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer. 2010; 46: 3158-3168.</mixed-citation><mixed-citation xml:lang="en">Amant F., Deckers S., Van Calsteren K. et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer. 2010; 46: 3158-3168.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hahn K.M., Johnson P.H., Gordon N. et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006; 107: 1219 -1226.</mixed-citation><mixed-citation xml:lang="en">Hahn K.M., Johnson P.H., Gordon N. et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006; 107: 1219 -1226.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Cardonick E., Dougherty R., Grana G., Gilmandyar D., Ghaffar S., Usmani A. Breast Cancer during pregnancy: maternal and fetal outcomes. Cancer J. 2010; 16: 76-82.</mixed-citation><mixed-citation xml:lang="en">Cardonick E., Dougherty R., Grana G., Gilmandyar D., Ghaffar S., Usmani A. Breast Cancer during pregnancy: maternal and fetal outcomes. Cancer J. 2010; 16: 76-82.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Dominici L.S., Kuerer H.M., Babiera G. et al. Wound complications from surgery in pregnancy-associated breast cancer (PABC). Breast Dis. 2010; 31: 1-5.</mixed-citation><mixed-citation xml:lang="en">Dominici L.S., Kuerer H.M., Babiera G. et al. Wound complications from surgery in pregnancy-associated breast cancer (PABC). Breast Dis. 2010; 31: 1-5.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Stensheim H., Moller B. van Dijk T., Fossa S.D. Cause-specific survival for women diagnosed with Cancer during pregnancy or lactation: a registry- based cohort study. J Clin Oncol. 2009; 27: 45-51.</mixed-citation><mixed-citation xml:lang="en">Stensheim H., Moller B. van Dijk T., Fossa S.D. Cause-specific survival for women diagnosed with Cancer during pregnancy or lactation: a registry- based cohort study. J Clin Oncol. 2009; 27: 45-51.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Cardonick E., Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004; 5: 283.</mixed-citation><mixed-citation xml:lang="en">Cardonick E., Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004; 5: 283.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Mir O., Berveiller P., Goffinet F. et al. Taxanes for breast cancer during pregnancy: a systematic rewiew. Ann Oncol. 2010; 21: 425-26.</mixed-citation><mixed-citation xml:lang="en">Mir O., Berveiller P., Goffinet F. et al. Taxanes for breast cancer during pregnancy: a systematic rewiew. Ann Oncol. 2010; 21: 425-26.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Williams S.F., Schilsky R.L. Antineoplastic drugs administered during pregnancy. Semin Oncol. 2000; 27: 618-622.</mixed-citation><mixed-citation xml:lang="en">Williams S.F., Schilsky R.L. Antineoplastic drugs administered during pregnancy. Semin Oncol. 2000; 27: 618-622.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Azim H.A. Jr., Azim H., Peccatori F.A. Treatment of cancer during pregnancy with monoclonal antibodies: a real challenge. Expert Rev. Clin Immunol. 2010; 6: 821-26.</mixed-citation><mixed-citation xml:lang="en">Azim H.A. Jr., Azim H., Peccatori F.A. Treatment of cancer during pregnancy with monoclonal antibodies: a real challenge. Expert Rev. Clin Immunol. 2010; 6: 821-26.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Cullins S.L., Pridjian G., Sutherland C.M. Goldenhar’s syndrome associated with tamoxifen given to the mother during gestation. JAMA. 1994; 271: 1905.</mixed-citation><mixed-citation xml:lang="en">Cullins S.L., Pridjian G., Sutherland C.M. Goldenhar’s syndrome associated with tamoxifen given to the mother during gestation. JAMA. 1994; 271: 1905.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Isaacs R.J., Hunter W., Clark K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy-case report and literature review. Gynecol Oncol. 2001; 80: 405- 408.</mixed-citation><mixed-citation xml:lang="en">Isaacs R.J., Hunter W., Clark K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy-case report and literature review. Gynecol Oncol. 2001; 80: 405- 408.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ardalan A., Bungum T. Gestational age and the risk of maternal breast cancer: A population based Case Control Study. Breast J. 2016; 22 (6) 657-661.</mixed-citation><mixed-citation xml:lang="en">Ardalan A., Bungum T. Gestational age and the risk of maternal breast cancer: A population based Case Control Study. Breast J. 2016; 22 (6) 657-661.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Pavlidis N., Pentheroudakis G. Metastatic involvement of placenta and foetus in pregnant women with cancer. Recent Results Cancer Res. 2008; 178: 183-94.</mixed-citation><mixed-citation xml:lang="en">Pavlidis N., Pentheroudakis G. Metastatic involvement of placenta and foetus in pregnant women with cancer. Recent Results Cancer Res. 2008; 178: 183-94.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Loibl S., Han S.N., von Minckwitz G., Bontenbal M., Ring A., Giermek J., Fehm T., Van Calsteren S.C., Schlehe B., Gziri M.M., Westenend P.J., Mьller V., Heyns L., Rack B., Van Calster B., Harbeck N., Lenhard M., Halaska M.J., Kaufmann M., Nekljudova V., Amant F. Treatment of breast cancer during pregnancy:.an observational study. Lancet Oncol. 2012 ; 13 (9): 887-896.</mixed-citation><mixed-citation xml:lang="en">Loibl S., Han S.N., von Minckwitz G., Bontenbal M., Ring A., Giermek J., Fehm T., Van Calsteren S.C., Schlehe B., Gziri M.M., Westenend P.J., Mьller V., Heyns L., Rack B., Van Calster B., Harbeck N., Lenhard M., Halaska M.J., Kaufmann M., Nekljudova V., Amant F. Treatment of breast cancer during pregnancy:.an observational study. Lancet Oncol. 2012 ; 13 (9): 887-896.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Amant F., Vandenbroucke T., Verheecke M. et al. Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. N Engl J Med. 2015; 373: 1824.</mixed-citation><mixed-citation xml:lang="en">Amant F., Vandenbroucke T., Verheecke M. et al. Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. N Engl J Med. 2015; 373: 1824.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Vandenbroucke T., Van Calsteren K., Amant F. Pediatric outcome after Maternal Cancer Diagnosed during Pregnancy. N Engl J Med. 2016; 374 (7) 693.</mixed-citation><mixed-citation xml:lang="en">Vandenbroucke T., Van Calsteren K., Amant F. Pediatric outcome after Maternal Cancer Diagnosed during Pregnancy. N Engl J Med. 2016; 374 (7) 693.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Aviles A., Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001; 2: 173-77.</mixed-citation><mixed-citation xml:lang="en">Aviles A., Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001; 2: 173-77.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Amant F., von Minckwitz G., Han S.N. et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013; 31: 2532.</mixed-citation><mixed-citation xml:lang="en">Amant F., von Minckwitz G., Han S.N. et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013; 31: 2532.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Litton J.K., Warneke C.L., Hahn K.M. et al. Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer. Oncologist. 2013; 18: 369.</mixed-citation><mixed-citation xml:lang="en">Litton J.K., Warneke C.L., Hahn K.M. et al. Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer. Oncologist. 2013; 18: 369.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Azim H.A. jr., Santorz L., Russell-Edu W., Pentheroudakis G., Pavlidis N., Peccatori F.A. Prognosis of PABC: A meta-analysis of 30 studies. Cancer treatment Reviews. 2012; 38 (7): 834-842.</mixed-citation><mixed-citation xml:lang="en">Azim H.A. jr., Santorz L., Russell-Edu W., Pentheroudakis G., Pavlidis N., Peccatori F.A. Prognosis of PABC: A meta-analysis of 30 studies. Cancer treatment Reviews. 2012; 38 (7): 834-842.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Loibl S., Han S.N. von Minckwitz et al. Treatment of breast cancer during pregnancy: an observational study. Jama Oncol. 2015; 1 (8) 1145-1153.</mixed-citation><mixed-citation xml:lang="en">Loibl S., Han S.N. von Minckwitz et al. Treatment of breast cancer during pregnancy: an observational study. Jama Oncol. 2015; 1 (8) 1145-1153.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Cardonick E.H. Overview of infertility and pregnancy outcome in cancer survivors up to date 2014.</mixed-citation><mixed-citation xml:lang="en">Cardonick E.H. Overview of infertility and pregnancy outcome in cancer survivors up to date 2014.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Azim H.A. Jr., Santoro L., Pavlidis N. et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer. 2011; 47: 74.</mixed-citation><mixed-citation xml:lang="en">Azim H.A. Jr., Santoro L., Pavlidis N. et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer. 2011; 47: 74.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Loibl S., Kohl J., Kaufmann M. Reproduction after breast Cancer. Zentrallblatt Gynekol. 2005; 127 (3): 120-124.</mixed-citation><mixed-citation xml:lang="en">Loibl S., Kohl J., Kaufmann M. Reproduction after breast Cancer. Zentrallblatt Gynekol. 2005; 127 (3): 120-124.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Lee S.J., Schover L.R., Partridge A.H. et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006; 24: 2917.</mixed-citation><mixed-citation xml:lang="en">Lee S.J., Schover L.R., Partridge A.H. et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006; 24: 2917.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Gadducci A., Cosio S., Genazzani A.R. Ovarian function and childbearing issues in breast cancer survivors. Gynecol Endokrinol. 2007; 23 (11): 625-631.</mixed-citation><mixed-citation xml:lang="en">Gadducci A., Cosio S., Genazzani A.R. Ovarian function and childbearing issues in breast cancer survivors. Gynecol Endokrinol. 2007; 23 (11): 625-631.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Tulandi T., Huang J.Y., Tan S.L. Preservation of female Fertility: An Essential Progress. Obstet Gynecol. 2008; 5: 1160-1172.</mixed-citation><mixed-citation xml:lang="en">Tulandi T., Huang J.Y., Tan S.L. Preservation of female Fertility: An Essential Progress. Obstet Gynecol. 2008; 5: 1160-1172.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">D’Agostino N.M., Edelstein K. Psychosocial challenges and resource need of young adult cancer survivors: implications for program development. J Psychosoc Oncol. 2013; 31: 585.</mixed-citation><mixed-citation xml:lang="en">D’Agostino N.M., Edelstein K. Psychosocial challenges and resource need of young adult cancer survivors: implications for program development. J Psychosoc Oncol. 2013; 31: 585.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Font-Gonzales A., Mulder R.L., Loeffen E.A. et al. Fertility preservation in children, adolescents and Young Adults with cancer: Reality of clinical practice guidelines and variations in recommendations. Cancer. 2016; 122: 2216-2223.</mixed-citation><mixed-citation xml:lang="en">Font-Gonzales A., Mulder R.L., Loeffen E.A. et al. Fertility preservation in children, adolescents and Young Adults with cancer: Reality of clinical practice guidelines and variations in recommendations. Cancer. 2016; 122: 2216-2223.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Ruddy K.J., Gelber S.I., Tamimi R.M. et al. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol. 2014; 32: 1151.</mixed-citation><mixed-citation xml:lang="en">Ruddy K.J., Gelber S.I., Tamimi R.M. et al. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol. 2014; 32: 1151.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Morrow P.K., Broxson A.C., Munsell M.F. et al. Effect of age and race on quality of life in young breast cancer survivors. Clin Breast Cancer. 2014; 14: e21.</mixed-citation><mixed-citation xml:lang="en">Morrow P.K., Broxson A.C., Munsell M.F. et al. Effect of age and race on quality of life in young breast cancer survivors. Clin Breast Cancer. 2014; 14: e21.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Barthelmes L., Davidson L.A., Gaffney C., Gateley C.A. Pregnancy and Breast cancer. BMJ. 2005; 330: 1375-1378</mixed-citation><mixed-citation xml:lang="en">Barthelmes L., Davidson L.A., Gaffney C., Gateley C.A. Pregnancy and Breast cancer. BMJ. 2005; 330: 1375-1378</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
